Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Restylane Skinboosters Vital + lidocaine is an **injectable dermal filler** specifically formulated with **20 mg/ml cross-linked non-animal stabilized hyaluronic acid (NASHA technology)** and **3 mg/ml lidocaine**. The product is designed to **boost skin hydration, elasticity, and smoothness**, primarily for the face, neck, décolletage, and hands. Hyaluronic acid attracts moisture and binds water in the dermis, improving skin quality and reducing fine lines and roughness. Lidocaine is included to minimize pain and discomfort during injection. This product is typically used in aesthetic medicine for mesotherapy-type skin rejuvenation in mature or sun-damaged skin, and is administered intradermally via prefilled syringes. Mechanism of action is via **biophysical hydration and volumization** of the dermis by hyaluronic acid, which integrates with skin tissue, and local anesthetic effect by lidocaine. Developed for professional medical use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Restylane Skinboosters Vital + lidocaine.